Results 11 to 20 of about 952,925 (309)

Fibrosis

open access: yesJournal of Translational Medicine, 2023
We are delighted to announce the launch of Fibrosis a new section of the Journal of Translational Medicine with the purpose of gathering current high-quality research to better understand the process of normal tissue repair as well as the pathogenetic mechanisms responsible for the onset and progression of tissue fibrosis that leads to organ ...
Pernia Marin, Monica, Salvatore, Mary
openaire   +4 more sources

Targeted exhaled breath analysis for detection of Pseudomonas aeruginosa in cystic fibrosis patients [PDF]

open access: yes, 2021
Background Pseudomonas aeruginosa (PA) is an important respiratory pathogen for cystic fibrosis (CF) patients. Routine microbiology surveillance is time-consuming, and is best performed on expectorated sputum. As alternative, volatile organic compounds (
Davies, Jane   +16 more
core   +1 more source

Scraping fibrosis: Expressway to the core of fibrosis [PDF]

open access: yesNature Medicine, 2011
Animal experiments using single organs as models of fibrosis spur therapeutic development toward promising targets, but testing of these therapies in human fibrosis yielded disappointing results and limited efficacy. Finding core pathways relevant in different organs that can become fibrotic will uncover molecules that will prove useful as therapeutic ...
Wajahat Z, Mehal   +2 more
openaire   +2 more sources

Cystic Fibrosis [PDF]

open access: yesDeutsches Ärzteblatt international, 2017
Universal screening of newborn babies for cystic fibrosis was launched in Germany on 1 September 2016. Here we present up-to-date information on the diagnosis, treatment, and prognosis of this disease.This article is based on relevant publications retrieved by a selective search in PubMed, along with guidelines from Germany and abroad and systematic ...
Susanne, Naehrig   +2 more
openaire   +4 more sources

Inflammasomes and Fibrosis [PDF]

open access: yesFrontiers in Immunology, 2021
Fibrosis is the final common pathway of inflammatory diseases in various organs. The inflammasomes play an important role in the progression of fibrosis as innate immune receptors. There are four main members of the inflammasomes, such as NOD-like receptor protein 1 (NLRP1), NOD-like receptor protein 3 (NLRP3), NOD-like receptor C4 (NLRC4), and absent ...
Wen-Juan Zhang   +5 more
openaire   +3 more sources

Incidence and risk factors of cancer in individuals with cystic fibrosis in the UK; a case-control study. [PDF]

open access: yes, 2021
To assess cancer incidence in the UK cystic fibrosis (CF) population and determine the associated risk factors, we undertook a nested case-control study of patients with CF, registered with the UK CF Registry.
Mentzakis, Emmanouil   +15 more
core   +1 more source

Lung Cancer in Pulmonary Fibrosis: Tales of Epithelial Cell Plasticity [PDF]

open access: yes, 2011
Lung epithelial cells exhibit a high degree of plasticity. Alterations to lung epithelial cell function are critically involved in several chronic lung diseases such as pulmonary fibrosis.
Königshoff, M.   +2 more
core   +1 more source

Guía de Práctica Clínica para el manejo nutricional de personas con Fibrosis Quística (GPC-FQ)

open access: yesRevista Española de Nutrición Humana y Dietética, 2017
La fibrosis quística (FQ) es una enfermedad multiorgánica, hereditaria, autosómica y recesiva cuyos problemas más frecuentes están relacionados con las alteraciones de los pulmones y del páncreas exocrino.
María Garriga   +7 more
doaj   +1 more source

Non-invasive ventilation and clinical outcomes in cystic fibrosis: Findings from the UK CF registry [PDF]

open access: yes, 2018
Background: Non-invasive ventilation (NIV) for respiratory failure and airway clearance is an established intervention in cystic fibrosis (CF), but its therapeutic benefit on lung function and survival remains under-investigated. Methods: Using data from
Bilton, D   +5 more
core   +1 more source

Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020 [PDF]

open access: yes, 2021
Funding Information: We thank the people with CF, and their families, for consenting to their data being included in the ECFSPR. We thank the centers and individual country representatives for allowing the use of the anonymized patient data.
European Cystic Fibrosis COVID project group   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy